Further Experimental Studies on the Production of Pulmonary Infarction:Especially from Coagulative and Fibrinolytic Studies
スポンサーリンク
概要
- 論文の詳細を見る
Attempts were made to clarify the mechanism with which the pulmonary infarction occurs, from coagulofibrinolytic point of view.The following results were obtained: (1) Pulmonary infarction could be produced at such a high rate as 74.4% through infusion of blood clots 2 days after intravenous injection of Lycopodium spores, when the coagulation activity was on the highest grade and the fibrinolytic activity was on the lowest grade.(2) Severe hemorrhage was observed in the post-mortem examination of the lungs 24 to 48 hours after infusion of the blood clots. The embolus remained thereafter, but the hemorrhage tended to diminish.(3) Consumption of coagulative factors and fibrinolytic factors was observed in the pulmonary venous blood than in the pulmonary arterial blood 3 hours after infusion of blood clots. Consumption of the coagula-tive and fibrinolytic factors and increase of F.D.P. were observed 12 to 24 hours after the infusion, although there were more or less differences depending upon experimental methods.(4) Consumption of free-type activator, increase of bond-type activator, and formation of marked focal lysis ring examined by means of fibrinolysis autograph were observed in tissue samples examined 24 to 48 hours after the infusion of blood clots.(5) It was assumed that a close relationship exists between the production of pulmonary infarction and the disorders of the coagulation-fibrinolytic system, especially the fibrinolytic factors including those in the blood and tissue samples, mainly examined around 24 hours after infusion of blood clots.
- International Heart Journal刊行会の論文
著者
-
Hasegawa Hiroshi
First Department Of Surgery Nippon Medical School
-
KAKIZAKI Hironobu
First Department of Medicine, Hokkaido University School of Medicine
-
MURAO Makoto
First Department of Internal Medicine, Hokkaido University School of Medicine
-
MURATA Hajime
First Department of Medicine, Hokkaido University School of Medicine
-
WATANABE Nobuo
First Department of Medicine, Hokkaido University School of Medicine
-
WATANABE Naoyoshi
First Department of Medicine, Hokkaido University School of Medicine
関連論文
- Pancreatic Enzyme Activity After a Pylorus-Preserving Pancreaticoduodenectomy Reconstructed with Pancreaticogastrostomy
- In situ Gene Transfer and Suicide Gene Therapy of Gastric Cancer Induced by N-Ethyl-N'-nitro-N-nitrosoguanidine in Dogs
- Cytotoxin Genes of Helicobacter pylori in Chronic Gastritis, Gastroduodenal Ulcer and Gastric Cancer: An Age and Gender Matched Case-Control Study
- A Prospective Randomized Trial of the Preventive Effect of Pre-operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma
- THE EFFECTS OF POSTURE ON CAPILLARY BLOOD FLOW PULSE AND GAS EXCHANGE IN THE LUNGS OF MAN
- Use of bromthymol blue, a pH indicator, for detecting the pancreatic duct orifice after resection of the head of the pancreats
- Complete duodenum-preserving resection of the head of the pancreas with preservation of the biliary tract
- Effects of Occlusion and Further Distension of Unilateral Pulmonary Artery with an Inflatable Balloon upon Systemic and Pulmonary Hemodynamics
- Role of Dextran Sulfate in Urokinase Therapy and Evaluation of the Effects by Estimation of Plasmin Inhibitor, Fibrinogenolytic Degradation Products, and Fibrinolytic Degradation Products
- Assay of Heparin in Plasma Using a Chromogenic Substrate and Its Clinical Applications
- Experimental Studies on the Production of Pulmonary Infarction (III):Especially from Coagulative and Fibrinolytic Studies
- Further Experimental Studies on the Production of Pulmonary Infarction:Especially from Coagulative and Fibrinolytic Studies
- Experimental Studies on the Production of Pulmonary Infarction:Especially from Coagulative and Fibrinolytic Studies
- Experimental Studies on the Production of Pulmonary Infarction (IV):Effects of UK, Heparin, t-AMCHA or Ellagic Acid
- Potential thrombolysis under selective infusion of autologous plasmin(AP) solution.